Cargando…
Mini-dose methotrexate combined with methylprednisolone as a first-line treatment for acute graft-versus-host disease: A phase 2 trial
BACKGROUND AND OBJECTIVES: Acute graft-versus-host disease (aGvHD) remains a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methylprednisolone (MP; 1–2 mg/kg/day) remains the standard first-line therapy for aGvHD, although no response is detected in nearly o...
Autores principales: | Xu, Zhengli, Mo, Xiaodong, Kong, Yuan, Wen, Qi, Han, Tingting, Lyu, Meng, Xu, Lanping, Chang, Yingjun, Zhang, Xiaohui, Huang, Xiaojun, Wang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474881/ https://www.ncbi.nlm.nih.gov/pubmed/37662885 http://dx.doi.org/10.2478/jtim-2023-0111 |
Ejemplares similares
-
Efficacy and Safety of Methotrexate in Combination with Mini Pulse Doses of Methylprednisolone in Severe Alopecia Areata. The Vietnamese Experience
por: Van, Anh Tran Thi, et al.
Publicado: (2019) -
Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients
por: Ma, Xiaodi, et al.
Publicado: (2023) -
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
por: Hamilton, Betty K., et al.
Publicado: (2023) -
Evaluation of risk for graft-versus-host disease in children who receive less than the full doses of mini-dose methotrexate for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation
por: Yum, Sook Kyung, et al.
Publicado: (2013) -
P1293: LOW-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE WITH G-CSF/ATG BASED HAPLOIDENTICAL PROTOCOL PROVIDES FAVORABLE DECREASE IN ACUTE GRAFT-VERSUS-HOST DISEASE FOR SAA PATIENTS
por: Xiao-DI, MA, et al.
Publicado: (2023)